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Abstract The biological effects of the cellular c-Myb and the
viral v-Myb proteins are strikingly different. While c-Myb is
indispensable for normal hematopoiesis, v-Myb induces acute
leukemia. The v-Myb DNA-binding domain (DBD) differs from
that of c-Myb mainly by deletion of the first of three repeats
which correlates with efficient oncogenic transformation and a
decrease in DNA-binding activity. To investigate the difference
in DNA-binding and transcriptional activation, oligonucleotide
selection and electrophoretic mobility shift assays were em-
ployed. The v-Myb DBD (R2R3) shows an intrinsic DNA-
binding specificity for an AT-rich downstream extension of the
Myb recognition element (MRE) PyAACT/GG for efficient
binding to this site, whereas R1 within the c-Myb DBD allows for
more flexibility for this downstream extension. Therefore, due to
the presence of repeat R1, c-Myb can bind to a greater number of
target sites. The intrinsic DNA-binding specificity of R2R3 is
further supported with the results from in vivo transcriptional
activation experiments which demonstrated that both the v-Myb
and c-Myb DBDs require an extension of the MRE (motif #1)
by a downstream T-stretch (motif #2) for full activity.
Surprisingly, the T-stretch improves binding when present on
either strand, but is required on a specific strand for transcrip-
tional activation.
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1. Introduction
The myb oncogene, which is unique in its hematopoietic
speci¢city of transformation, was ¢rst discovered in two in-
dependently derived avian retroviruses that cause acute leuke-
mia (for review, [1]). Both AMV and the E26 virus encode v-
Myb proteins that are truncated versions of the cellular c-Myb
protein. The normal c-myb proto-oncogene encodes a 75 kDa
nuclear protein that is expressed at high levels in immature
hematopoietic cells. Its expression decreases as these cells dif-
ferentiate [2,3]. Lack of c-myb results in failure of intrafetal
hematopoiesis [4]. On the other hand, the AMV v-myb onco-
gene speci¢cally blocks monoblast di¡erentiation which re-
sults in transformation of macrophage precursors [5]. The
fact that these two related proteins cause such dramatic cel-
lular e¡ects provides a framework for studying how the viral
and the cellular Myb proteins interact with DNA target sites.
The c-Myb DNA-binding domain (DBD) consists of three
tandem imperfect repeats of approximately 50 amino acids
(R1, R2 and R3) [6]. During the genesis of v-Myb, deletion
of most of the ¢rst repeat (R1) has occurred ([7^9]. The min-
imal region of c-Myb that is both necessary and su⁄cient for
sequence-speci¢c DNA-binding has been narrowed down to
repeats R2 and R3 [7,10^12] and unlike many other sequence-
speci¢c DNA-binding proteins, the Myb proteins appear to
bind to DNA as monomers [10,11]. Though repeat R1 was
not shown to be involved in sequence-speci¢c recognition, it
has been suggested to increase the a⁄nity of the protein for
DNA and the stability of the Myb-DNA complex [13^17].
Selection of a pool of chicken genomic DNA fragments led
to the identi¢cation of the v-Myb recognition sequence
PyAACT/GG (Myb recognition element = MRE) [7]. Three
such MREs were found 5P of the transcriptional start site of
the E26-inducible mim-1 gene [18]. Recently, three indepen-
dent groups have reported the results of NMR-based studies
of the minimal c-Myb R2R3 DBD [19,20] and the minimal
B-Myb R2R3 DBD [21,22]. Each repeat contains three con-
served tryptophans spaced 18 or 19 amino acids apart [23]
that form a hydrophobic core [24] and that play a critical
role in sequence-speci¢c DNA-binding [23,25,26]. Each repeat
can fold into three helices that form a helix-turn-helix-related
structural motif as was shown by NMR spectroscopy [20^
22,24]. Though there is a high degree of amino acid conserva-
tion between individual repeats, the structural data imply that
repeats R2 and R3 of both the c-Myb and the B-Myb DBD
do not fold into the same exact tertiary structure [19,21,22].
R3 folds into a helix-turn-helix-related motif of which the
C-terminally located third helix is the recognition helix which
makes speci¢c contacts within the major groove of the DNA
double helix. Repeat R2 does not contain such a stable pre-
formed recognition helix at its C-terminus. Therefore, it has
been suggested that the conformational instability of the
DNA-binding site on the protein may be necessary to allow
for binding to a number of di¡erent speci¢c DNA target sites.
Besides the N-terminal truncation which deletes most of
repeat R1 of the Myb DBD, four amino acid substitutions
are present within the v-Myb DBD. As expected from the
similarity within the DBD region, the only observed di¡erence
in terms of binding of these two proteins to the MRE is a
reduced a⁄nity of the v-Myb protein by a factor of 5^6
[13,14,17] when compared to the c-Myb protein
(KdW4U10310 M, [17]). Two extended consensus sequences
were derived from an ampli¢cation-based selection of a pool
of random sequences: the 9 bp YAACBGYCR [27] and the
8 bp YAACKGHH [28]. These two extended sites were found
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both for the v-Myb and the chicken [28] and mouse [27]
c-Myb protein.
Consistent with this ¢nding, puri¢ed c-Myb R2R3 and
c-Myb R1R2R3 protect the same target sites with the same
positions of the borders in exonuclease-III footprinting assays
[14]. In contrast, a large di¡erence was observed in how the
border in the two complexes withstood exonuclease attack [14]
which was attributed to the presence of repeat R1 in the
c-Myb DBD. A stabilizing e¡ect was observed for the down-
stream border once repeat R1 was present in the DNA-pro-
tein complex [14].
To better understand how individual repeats of the c-Myb
and the v-Myb protein function in binding to speci¢c DNA
targets in order to activate transcription, di¡erent repeat com-
binations were used in this study to investigate the c-Myb and
v-Myb-DNA interactions in relation to di¡erent MRE £ank-
ing sequences.
2. Materials and methods
2.1. Random site selection
Selection and ampli¢cation of high-a⁄nity binding sites for the
Myb proteins were performed essentially as described elsewhere [29].
For selection, the 60 base oligonucleotide PCRP-RSS#6 (5P-CGGGA-
TATCTCTAGAGATGG(N20)GAGGCCTGCAGGATATCGTA-3P)
was used, which contains 20 random nucleotides £anked on either side
by 20 bases of de¢ned sequence to permit PCR ampli¢cation. PCR
ampli¢cation involved the primers PCRP-RSS#4 (5P-CGGGAT-
ATCTCTAGAGATGG-3P) and PCRP-RSS#5 (5P-TACGATAT-
CCTGCAGGCCTC-3P) in a 50 Wl total reaction volume for 20 cycles
of 95‡C for 45 s/59‡C for 1 min/73‡C for 30 s. After precipitation of
the reaction mix, the DNA was labelled using T4 DNA polymerase
(New England Biolabs) and [K-32P]dCTP. Binding reactions of end-
labelled DNA and puri¢ed proteins were carried out in a ¢nal volume
of 20 Wl containing 20 mM Tris-Cl (pH 7.5), 3 mM MgCl2, 50 mM
NaCl, 15% (v/v) glycerol and 2 Wg poly [dI-dC]. The binding mixture
was incubated on ice for 10 min, separated using a 6% polyacrylamide
gel (29:1 acrylamide:bisacrylamide) and radiolabelled DNA-binding
sites were excised from the gel. After elution and puri¢cation, half of
the DNA was used for the next round of DNA ampli¢cation and
selection. After the ¢fth round of PCR ampli¢cation, the gel-puri¢ed
DNA fragments were cloned into the TA-cloning vector pCRII (In-
vitrogen) and the inserts were sequenced by the dideoxy sequencing
method [63].
2.2. Electrophoretic mobility shift assay (EMSA)
The methods used for EMSAs are essentially as described elsewhere
for other DNA-binding proteins [64] and include separating free DNA
from protein-complexed DNA on electrophoretic mobility shift gels.
Double-stranded DNA probes with four nucleotide overhangs were
3P end-labelled by end-¢lling with [K-32P]dATP and Klenow enzyme
(New England Biolabs). Binding reactions were carried out in a ¢nal
volume of 10 Wl containing 20 mM Tris-Cl (pH 7.5), 3 mM MgCl2,
50 mM NaCl, 15% (v/v) glycerol and 2 Wg poly [dI-dC], end-labelled
DNA fragment and protein sample. Bacterially expressed Myb DBDs
were used for the EMSA. The binding mixture was incubated for
10 min on ice before separated on a 6% polyacrylamide gel (29:1
acrylamide:bisacrylamide).
2.3. Cell culture, transient DNA transfection, nuclear extracts and
L-galactose and luciferase assays
Quail QT6 cells were grown in Dulbecco’s modi¢ed essential Ea-
gle’s medium (DMEM) supplemented with 5% fetal calf serum, glu-
cose (4.5 g/l), 1Unon-essential amino acids, 2 mM L-glutamine, 1 mM
sodium pyruvate, streptomycin (100 Wg/ml) and penicillin (100 U/ml)
in a humidi¢ed 10% CO2-90% air incubator at 37‡C. Transient trans-
fections were performed by a modi¢ed calcium phosphate precipita-
tion method [65,66]. Myb-expressing activator plasmids or control
vector-only plasmid N-Cla (3 Wg), luciferase reporter plasmid (1 Wg),
carrier tRNA (to give a total of 10 Wg of nucleic acid for transfection)
and 0.5 Wg of internal control plasmid expressing L-galactosidase from
the cytomegalovirus promoter (CMV-L-gal) were co-transfected into
approximately 106 QT6 cells per 10 cm diameter plate. Two days
later, the cells from each transfection plate were scraped in phos-
phate-bu¡ered saline. Half of these cells were used for a luciferase
assay [67,68] and a L-galactosidase assay [69], the other half was
solubilized by boiling for 3 min in sodium dodecyl sulfate (SDS)-
polyacrylamide gel electrophoresis (PAGE) loading dyes and sub-
jected to immunoblotting to demonstrate expression of Myb in trans-
fected cells.
The method used to prepare nuclear cell extracts which include
Myb proteins is essentially as described by others [70].
2.4. Western blot analysis
Normalized volumes of QT6 lysates (based on internal L-Gal activ-
ity for transient transfections) were subjected to SDS-PAGE (10^15%
polyacrylamide) and then, the transiently expressed proteins were
transferred to a nitrocellulose membrane (BA-S 83; Schleicher and
Schuell) and detected with anti-Myb antibody (mouse monoclonal
Myb 5E antibody, [71]). Immunodetection was performed using an
enhanced chemiluminescence system (Pierce).
3. Results and discussions
3.1. v-Myb requires an AT-rich downstream extension of the
MRE for e⁄cient binding
In an e¡ort to clarify whether the sole function of repeat R1
is to contribute to the stability of the c-Myb-DNA complex as
previously suggested [13,14] and not to be involved in se-
quence-speci¢c DNA-binding, we employed the random oli-
gonucleotide site selection strategy [29] using di¡erent combi-
nations of puri¢ed Myb DBD repeats (c-Myb R1R2R3,
c-Myb R2R3, c-Myb R1R2 and v-Myb R2R3). From the
obtained selected sequences, several conclusions can be
drawn. As shown in Fig. 1A, the majority of the sequences
obtained for c-Myb R1R2R3 and v-Myb R2R3 contain the
proposed v-Myb consensus site TAACNG/T with the MRE
core element AAC which has been shown before by others
C
Fig. 1. A: Binding site selection data with puri¢ed Myb DBDs. Consensus Myb-binding sites derived for c-Myb R1R2R3, c-Myb R2R3 and
v-Myb R2R3 from analysis of selected sequences. The three MREs of the 5P non-coding region of the mim-1 gene are shown as a comparison.
B^D: DNA-binding assays using EMSA. B: Sequence of double-stranded DNAs used in the DNA-binding assays. All the oligonucleotides
used were 26 bp long. The MRE region along with the downstream £anking T-stretch are shown in bold. Every base that is di¡erent in com-
parison to the original mim1A site is underlined. * Highlights the bases that represent a mismatch at position 3 or 4 within the T or the dT se-
quence (mim1A-dTm3, mim1A-dTm3+4, mim1A-m3 or mim1A-m3+4). C: The v-Myb DBD shows a dependency for the downstream AT-rich
sequence. Analyses of c-Myb R1R2R3 and v-Myb R2R3 -mim1A, -mim1A-dT, -mim1A-m3 and -mim1A-int3 complexes were performed (only
some examples are shown). Free DNA is shown in lanes 1, 6, 11 and 16. Binding reactions with an increasing amount of the c-Myb R1R2R3
protein (upper gel) or v-Myb R2R3 (lower gel) are shown in lanes 2^5, 7^10, 12^15 and lanes 17^20. Myb-speci¢c DNA-protein complexes
and free DNA probes are marked on the left of the gel. D: Quantitative analysis of EMSAs done in B. Shown are averages of three experi-
ments. For quantitative analysis of the DNA-binding assays, we compared each fraction of DNA bound by equal amounts of protein and
measured the relative amount of radioactivity in free versus bound DNA using the phosphorimager (Molecular Dynamics). The relative values
were normalized against the corresponding mim1A value for each protein concentration. For each DNA fragment, the normalized values from
the various protein concentrations were averaged to assign a value for protein a⁄nity.
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[7,27,28]. Second, roughly 75% of the MRE containing se-
quences selected with c-Myb R1R2R3 and 85% of the se-
quences selected with v-Myb R2R3 showed a region rich in
As and/or Ts downstream of the MRE. The c-Myb DBD
showed a preference for Ts, whereas the v-Myb DBD showed
a preference for As. Similar results were obtained for v-Myb
R2R3 and c-Myb R2R3 without the amino acid substitutions
of AMV. Third, site selection experiments with the c-Myb
R1R2 protein, which binds only weakly to the mim1A site
[13], did not yield any speci¢c target DNA (results not
shown), which tells us that these two repeats are not su⁄cient
to bind to DNA speci¢cally. This is particularly interesting
because it suggests that even though there is a high degree of
sequence conservation between individual c-Myb DBD re-
peats (R1, R2 and R3), they do not seem to fold into the
same tertiary structure. As mentioned above, this has already
been shown with the NMR structure for repeats R2 and R3 of
the minimal c-Myb R2R3 protein [19] and the minimal B-
Myb R2R3 protein [21]. In addition, several di¡erent tran-
scriptional regulators have been identi¢ed that contain more
distantly related Myb repeats [30]. These Myb repeat contain-
ing proteins can be grouped into di¡erent families, including
the telobox family [31], the SANT domain family of transcrip-
tional regulators [32] and the transcription terminator family
[33]. Except for the SANT domain containing proteins, all of
these Myb domain containing proteins do have intrinsic
DNA-binding activity. Therefore, the Myb repeats within
the SANT domain containing proteins must have another
function. This function could either be involved in protein-
protein interaction such as has been shown for cyclin D [34]
or it could be involved in unspeci¢c protein-DNA interaction
as is suggested for repeat R1 [13,14]. From these site selection
data, we conclude that repeat R1 does not contribute to spe-
ci¢c DNA-binding, but increases the a⁄nity of c-Myb for the
MRE, especially in the presence of an AT-rich downstream
sequence.
As shown in Fig. 1A the mim1A element of the 5P region of
the mim-1 gene contains a stretch of six Ts downstream of
the MRE TAACGG [18]. This is particularly interesting since
the mim1A element is a naturally occurring MRE for which
the c-Myb protein shows the highest a⁄nity [18]. Given the
close resemblance of the selected sequences for both the c-
Myb and v-Myb DBD with the strong mim1A site, we de-
cided to investigate the relationship of this T-stretch to the
MRE in terms of DNA-binding and subsequent trans-activa-
tion.
Certain nucleotide sequences spontaneously impart a pre-
ferred direction of curvature on a DNA molecule, for example
by originating an intrinsic bend [35,36]. Although A or T
tracts are believed to be major determinants of DNA cur-
vature, the sequence context also plays a critical role [37].
PolyA/polyT tracts are particularly rigid and bending may
occur preferentially at the A/T boundaries [38^40]. In partic-
ular, polyA/polyT tracts adopt a Z-like DNA conformation
and this gets separated from normal B-like DNA by a local
bend at the junction of the two structures [40]. Therefore, the
stretch of six Ts downstream of the MRE in the mim1A site
might have a dramatic e¡ect on the local promoter structure.
In addition, sequences that are rich in ATs compared to GC-
rich sequences have a lower melting temperature and are
therefore less stable. In other words, if binding to a protein
to DNA requires melting of one or more base pairs, then, the
binding of mismatched base pairs should be favored over AT
pairs that in turn should bind better than GC pairs. To gain
insight into the structural e¡ects of DNA sequences in the
formation of speci¢c Myb-MRE complexes, we used EMSAs
to test the e¡ect of di¡erent downstream £anking sequences
upon Myb-binding to the same core MRE. We designed dif-
ferent double-stranded DNAs (see Fig. 1B) to be tested with
quantitative EMSA to be able to discriminate between the two
di¡erent possibilities, such as bending or melting.
Interestingly, when the v-Myb DBD was tested in compar-
ison to the c-Myb DBD, we observed that the v-Myb R2R3
protein shows a much greater requirement for the downstream
AT-rich sequence than the c-Myb R1R2R3 protein (see Fig.
1C,D). This preference was also re£ected in the pool of se-
lected oligonucleotides: 85% of oligonucleotides selected by
v-Myb R2R3 contain an AT-rich downstream sequence com-
pared to only 75% selected by c-Myb R1R2R3. Deletion of
the T-stretch and introduction of a random sequence (mim1A-
6
Fig. 2. Trans-activation by the Myb proteins requires an extension of the MRE by a T-stretch. A: Structure of the di¡erent Myb-VP16 fusion
proteins used in this study. The c-Myb VP16 protein (CCVP16), v-Myb VP16 protein (dVVP16) and various mutant forms are diagrammed.
The gray boxes indicate the highly conserved Myb DBD, which is composed of three imperfect direct repeats of approximately 50 amino acids
each. The black box represents the 78 amino acid transcriptional activation domain of the herpes simplex virus VP16 which is fused to various
Myb N-termini as diagrammed. The di¡erent activator constructs used have been described elsewhere: CCVP16 (c-Myb VP16), dCVP16 and
dVVP16 (v-Myb VP16) [5,13]. The truncations of Myb are named according to the sequence present in c-Myb (C) or absent in v-Myb (D)
[13]. The vertical bars within dVVP16 indicate amino acid substitutions in v-Myb relative to c-Myb. The c-Myb mutant designated CC
SS(11,12)AAVP16 represents site-directed mutagenesis of the CKII phosphorylation sites, whereas the c-Myb mutant designated d1^30 (CC(d1^
30)VP16) has a N-terminal deletion of 30 amino acids including the CKII sites and an adjacent acidic region just upstream of the Myb DBD
[13]. B: Trans-activation by di¡erent Myb VP16 fusion proteins. The animal cell reporter constructs polyA-E1b-luc(3Umim1A) (three tandem
TAACCGTTTTTT sites), polyA-E1b-luc(3Umim1A-dT) (three tandem TAACCGTTGACG sites) and polyA-E1b-luc(3Umim1A-Tos) (three
tandem TAACCGAAAAAAT sites) all harbor a simian virus 40 polyA site and three mim1A Myb-binding sites (underlined) with di¡erent
downstream £anking sequences (bold) upstream of an E1b TATA box and the luciferase gene followed by another SV40 polyA site. Activities
are shown for each protein relative to the E1b-luc(3Umim1A) reporter construct, which was assigned a value of 100 (black bar) after normaliz-
ing for the transfection e⁄ciency using a CMV-L-gal reporter. Data are averages of three experiments. Error bars indicate S.D.s. C: Immuno-
blot analysis of Myb proteins of the same transfected cell extracts. Relative mobilities of transfected Myb VP16 fusion proteins are labelled on
the right of the gel: 1 = CCVP16 (c-Myb VP16), 2 = CC SS(11,12)AAVP16, 3 = CC(d1^30)VP16, 4 = dVVP16 (v-Myb VP16) and 5 = dCVP16.
N-Cla is the retroviral vector [13] which does not encode a functional activator protein. D: Binding of Myb VP16 fusion proteins to di¡erent
reporter genes. Free DNA is shown in lanes 1, 5 and 10. Incubation of binding reactions with control cell extracts (N-Cla = retroviral vector
[13] which does not encode a functional activator protein) is shown in lanes 2, 6 and 11. Binding reactions with the c-Myb VP16 (N-CVP16)
cell extract are shown in lanes 3, 8 and 12, whereas the binding reactions with the v-Myb VP16 (N-dVVP16) cell extract are shown in lanes 4,
9 and 13. Myb-speci¢c DNA-protein complexes and free DNA probes are marked on the left of the gel. Background bands observed after the
incubation of probes with nuclear extracts are marked on the left of the gel (b).
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dT) greatly a¡ected binding of the v-Myb DBD domain (re-
peats R2 and R3) to the MRE, whereas the c-Myb DBD
(repeats R1, R2 and R3) did not seem to be a¡ected. An
interruption of the T-stretch by placing a G at position T(3)
(mim1A-Tint3) or placing a mismatch at position T(3) or
positions T(3)+T(4) both in the wild-type mim1A sequence
(mim1A-Tm3/mim1A-Tm3+4) or in the mim1A sequence
that has the downstream T-stretch deleted (mim1A-dTm3/
mim1A-dTm3+4) again a¡ected binding of v-Myb to the
MRE, but not of c-Myb (see Fig. 1D). To some extent, the
mismatches can compensate for the absence of AT-rich DNA
for the v-Myb DBD (mim1A-dTm3/mim1A-dTm3+4). Inter-
estingly, the c-Myb DBD seemed not be a¡ected to the same
degree and the only di¡erence between these two proteins is
the presence of four amino acid substitutions and the absence
of most of repeat R1 in the v-Myb DBD. Since we obtained
very similar results for the c-Myb R2R3 protein as for the
v-Myb R2R3 protein (results not shown), we can rule out that
the four amino acid substitutions have an e¡ect in these gel
shift assays. This clearly points to a new and important func-
tion for repeat R1. In addition, neither c-Myb R1R2R3 nor
v-Myb R2R3 seem to care on which strand the T-stretch is
located. A quantitative analysis of the EMSAs shown in Fig.
1C is summarized in Fig. 1D. Relative a⁄nities were deter-
mined by analyzing binding of various protein concentrations
using the same amount of wild-type or mutant DNA. All the
measurements were done within the linear range of the assay
to avoid protein excess which would result in saturation.
These results suggest that for the Myb proteins to form a
stable Myb-MRE complex, a certain tertiary complex has to
be formed which can be facilitated by the presence of a down-
stream AT-rich sequence. Since the c-Myb protein can bind to
a bigger pool of target sites and shows less of a dependency
on the downstream £anking sequence, we believe that repeat
R1 can function as a ‘wedge’ in the formation of the Myb-
MRE complex. This wedge would open up neighboring down-
stream sequences in the presence and absence of AT-rich se-
quences so that the same stable complex can be formed. This
conclusion strongly supports the idea that R1 is not involved
in speci¢c DNA-binding, but rather in increasing the stability
of the Myb-DNA complex [13^16].
3.2. In vivo trans-activation by the Myb proteins requires an
extension of the MRE by a downstream T-stretch
Further insight about the contribution of downstream
£anking sequences and the successful formation of the Myb-
MRE complex can be gained by comparing the binding capa-
bilities of di¡erent Myb proteins to the MRE to their ability
to activate transcription in vivo. The results of the trans-acti-
vation assays in QT6 cells are summarized in Fig. 2B. All the
Myb proteins tested were VP16 fusion proteins (see Fig. 2A)
which allowed us to study the N-terminal contribution of the
di¡erent proteins in DNA-binding and trans-activation with-
out the complications and speci¢c intramolecular actions
within full-length Myb proteins. We tested three di¡erent
Myb-responsive reporters in this type of assay: wild-type
mim1A (three mim1A sites), mim1A with a deletion of the
downstream T-stretch (three mim1A-dT sites) and mim1A
with the T-stretch on the opposite strand (three mim1A-Tos
sites) (see Fig. 2).
Three main conclusions can be drawn from these sets of
assays. First, the v-Myb DBD (dVVP16) is more sensitive
than the c-Myb DBD (CCVP16) to whether the T-stretch is
present or not (compare mim1A with mim1A-dT), which sup-
ports our in vitro DNA-binding studies (see above and Fig.
1A,D). Once the T-stretch was deleted and replaced by a
random sequence (mim1A-dT), transcriptional activity of
dVVP16 was decreased the most (by 80%), whereas CCVP16
was less a¡ected (by 60%). This is in agreement with what we
have seen in the EMSAs. The v-Myb DBD shows a higher
dependency for the downstream T-stretch compared to the c-
Myb DBD for DNA-binding. In addition, dCVP16, which is
the c-Myb DBD without repeat R1, is less a¡ected than
dVVP16 and the only di¡erence is the presence of four amino
acid substitutions in the v-Myb DBD. Our in vitro EMSAs
did not reveal a di¡erence for the c-Myb R2R3 compared to
the v-Myb R2R3 DBD. Therefore, trans-activation of these
two proteins is again not just dependent on DNA-binding, but
rather on the formation of the proper protein-DNA complex.
These QT6 assays with the di¡erent reporter constructs can
therefore be used as an assay to study the contribution of the
di¡erent amino acid substitutions and their contribution in
trans-activation. We also tested the mutant CC
SS(11,12)AA, in which both serines, the CKII phosphoryla-
tion sites at position 11 and 12 [41], were substituted with
alanines [13]. Further, we tested the deletion mutant CC d1^
30, which lacks the ¢rst 30 amino acids including serine 11
and 12 and an adjacent stretch of acidic amino acids [13].
Phosphorylation of serine 11 and 12 was reported to reduce
DNA-binding activity [42], whereas experiments with a short-
er form of c-Myb that lacks the entire C-terminus implied just
the opposite, namely that phosphorylation of Ser 11 and 12
by CKII increases DNA-binding activity [43]. In addition, our
lab showed that deletion of the ¢rst 30 amino acids (d1^30)
upregulates both DNA-binding and transcriptional activation
[13]. In general, it seems that CKII (Ser-11 and Ser-12, absent
in v-Myb) potentially regulates c-Myb function through the
N-terminal domain [13,41,43]. When tested with di¡erent re-
porter constructs, trans-activation by CC(d1^30)VP16 and CC
SS(11,12)AAVP16 were the least a¡ected (Fig. 2B).
Strikingly, all of the Myb proteins tested showed a strict
requirement for the T-stretch to be located on the top strand,
just downstream of the MRE. If placed on the bottom strand
(mim1A-Tos), no transcriptional activation was measured
which is a new and surprising observation.
Given the absence of other well-developed experimental
systems for addressing DNA-bending and transcriptional ac-
tivation in vivo, our approach seems to be su⁄ciently sensitive
to directly analyze the in£uence of nearby DNA structures on
a given DNA-protein complex. We are quite comfortable with
the idea that the di¡erences in trans-activation observed for
the di¡erent reporter constructs is due to the in£uence of the
neighboring £anking DNA sequence and not due to the actual
MRE. We also tested the DNA-binding activity of the Myb
proteins from transfected QT6 nuclear extracts to the di¡erent
reporter sequences using EMSA. Fig. 2D shows binding of the
two proteins v-Myb VP16 (N-dVVP16) and c-Myb VP16
(N-CCVP16) to the mim1A, the mim1A-dT and the
mim1A-Tos sites. It is clear that both proteins still show spe-
ci¢c binding to the MRE with di¡erent downstream £anking
sequences even in the presence of high amounts of competitor
(2 Wg poly [dI-dC] in a 20 Wl reaction volume). Therefore,
these gel shift experiments with nuclear extracts support our
in vitro experiments with puri¢ed proteins that DNA-binding
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Fig. 3. A Model of Myb-speci¢c transcriptional activation. Induction of transcription by the Myb proteins either through direct or indirect con-
tacts with the basal transcription machinery requires a speci¢c promoter structure. A speci¢c Myb-MRE complex needs to be formed. This pro-
moter structure can be obtained by two di¡erent mechanisms: (1) speci¢c sequence-induced bend or (2) protein-induced bend. Both types of
mechanisms would result in a positive induction of Myb-speci¢c transcription. Therefore, a Myb-speci¢c promoter should include, besides the
MRE (motif #1), either a motif #2, which is a stretch of six Ts, or another proximal located UAS element for another factor that induces the
same kind of structural changes into the DNA which is required for transcription to occur. The exact location of the ‘Y’ UAS element relative
to the MRE PyAACT/GG is unclear and is drawn immediately following the MRE as an example in this ¢gure. B: Cooperation of Myb with
other transcription factors. In each case, a Myb family protein and a DNA-binding protein of another family have been shown to co-regulate
a speci¢c target gene by occupation of adjacent binding sites within the promoter. c-Myb and C/EBP (b-ZIP) regulate the chicken mim-1 gene
[58], c-Myb and AML1 (Runt) regulate the murine T-cell receptor [59], C1 (Myb) and R (helix-loop-helix) regulate the maize Bronze1 gene
[60], Bas1 (Myb) and Bas2/Pho2 (Homeo) regulate the yeast HIS4 gene [61].
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occurs regardless of which strand the T-stretch is on. In ad-
dition, the observed di¡erence in trans-activation (Fig. 2B) is
not due to a di¡erence in protein level within the QT6 cells as
is shown in the immunoblot in Fig. 2C.
From the in vitro DNA-binding studies, we have learned
that there is a dependency of the Myb DBD, in particular of
the R2R3 v-Myb DBD, for the downstream AT-rich £anking
sequence, though it seemed not to matter what the exact se-
quence was. Therefore, we concluded that DNA melting or in
other words DNA ‘breathing’ is likely to be an important
mechanism involved in the formation of a stable Myb-MRE
complex. The in vivo trans-activation experiments extended
this model by including another level of DNA structure, pos-
sibly DNA-bending. As mentioned above, a stretch of six Ts
downstream of the MRE is required for the Myb proteins to
form a stable DNA-protein complex that is capable of initiat-
ing transcription. This means that the DNA must adopt a
certain conformation such as a local bend with a given ori-
entation which in£uences binding of the Myb proteins to the
neighboring MRE.
3.3. The Myb proteins require a local DNA distortion for
e⁄cient trans-activation
The present study establishes the requirement of an exten-
sion of the MRE (motif #1) PyAACT/GG [7] by a down-
stream stretch of six Ts (motif #2), such as is found in the
naturally occurring mim1A site within the mim-1 promoter
[18], for e⁄cient binding and transcriptional activation by
the Myb proteins. In terms of DNA-binding, the presence
or absence of repeat R1 to some extend in£uences the intrinsic
speci¢city of the Myb DBD for the MRE. N-terminal deletion
of the c-Myb DBD to the v-Myb DBD equivalent showed a
greater dependency for the T-stretch for e⁄cient Myb-DNA
complex formation, whereas the c-Myb DBD showed a re-
laxed dependency. The exact sequence of the downstream
MRE element seems not to be important, as long as it is
rich in A and T nucleotides, which suggests that melting of
the downstream base pairs is a requirement for the transcrip-
tional active protein-DNA complex formation. Experiments
with the mismatched double-stranded DNA mim1A-m3 and
mim1A-m3+4 support this notion. Random oligonucleotide
selection and EMSAs revealed that repeat R1 within the
c-Myb DBD does not contribute to speci¢c DNA-binding,
but seems to increase the a⁄nity of the c-Myb protein for
an MRE in the presence of an AT-rich sequence. In addition,
R1 seems to be necessary and su⁄cient for the c-Myb DBD to
be able to bind to a MRE without a downstream T-stretch.
This implies that repeat R1 stabilizes the c-Myb-DNA com-
plex by functioning as a ‘wedge’ which opens up neighboring
DNA sequences other than AT-rich stretches. In summary,
this explains why the c-Myb protein can bind to a greater
number of di¡erent target sites.
Astonishingly, once speci¢c Myb-DNA complexes were
formed, an additional level of speci¢city was observed for
transcriptional activation by the Myb proteins to occur. Tran-
scriptional activation by the Myb proteins showed a strict
requirement for the T-stretch (motif #2) downstream of the
MRE (motif #1) TAACGG, which suggests that a speci¢c
Myb-DNA complex had to be formed that is highly depen-
dent on the local DNA structure. As mentioned above, at the
boundary of a stretch of six Ts, a bend can occur [38^40].
Bendable DNA can allow for a mixture of many di¡erent
conformational states, the equilibrium of which can be dis-
placed towards one speci¢c form by external forces such as
proteins interacting with them [44,45]. The speci¢city of
DNA-protein contacts is not only the result of direct recog-
nition of certain bases within the major groove of the DNA
with speci¢c amino acids of the protein, but also of an array
of interactions between the protein and DNA surfaces not
necessarily linked to a particular nucleotide sequence. This
type of interaction has ¢rst been described for the trp repres-
sor/operator complex [46] and has been termed indirect read-
out as opposed to the direct interaction of individual base
pairs. Indirect readout involves protein contacts with the sug-
ar-phosphate backbone of DNA through ionic bridges, hy-
drogen bonds and hydrophobic interactions. Both indirect
and direct interactions contribute to the speci¢city and stabil-
ity of a particular DNA-protein complex and require the pro-
tein and the DNA to accommodate each other in order to set
up adequate contacts such as conformational distortions,
which may be required in both partners to achieve an optimal
¢t [38,47]. The extent to which sequence-dependent bendabil-
ity of DNA plays a key role in the formation of a functional
Myb-DNA complex is clearly re£ected in our trans-activation
data. A Myb-responsive reporter in which the downstream T-
stretch (motif #2) was placed on the opposite strand (E1b-
luc(3Umim1A-Tos)) leaving an A-stretch downstream of the
MRE (motif #1) essentially abolished the promoter activity.
Since it is known that polyA/polyT tracts are particularly
rigid and that bending may occur at the boundary of such a
tract [38^40], it is likely that changing the sequence from a
T-stretch to an A-stretch would change the orientation of a
bend by 180‡ around the axis of the MRE double helix. In
other words, it would completely distort the local promoter
structure. This is what we have observed with the E1b-luc-
(3Umim1A-Tos) reporter construct, because we did not ob-
tain any transcriptional activity for the Myb proteins. Fur-
ther, DNA transiently transfected into animal cells is partially
organized into chromatin [48]. Strand speci¢city of the T-
stretch could in£uence the position of a nearby nucleosome
which in turn a¡ects binding of adjacent proteins. The in vitro
DNA-binding assays were all done with ‘naked’ DNA, where-
as transcriptional activation assays in transiently transfected
QT6 cells re£ects a more in vivo-like situation. Recent data
from our lab already demonstrated that the quality of the
MRE determines the readout of Myb transcriptional activity.
In particular Myb proteins, even when tethered to the strong
VP16 activation domain, did not activate but rather repressed
the N-ras promoter [49]. These results support a model in
which the DNA recognition site itself can act as an allosteric
e¡ector of transcriptional regulation [50].
The promoter region of the E26-inducible mim-1 gene con-
tains three closely spaced Myb-binding sites [18] and is
strongly activated by v-Myb and c-Myb in transient transfec-
tion assays. The mim1A site is the strongest of the three Myb-
binding sites and is required for this activation in transient
assays. Recently, additional Myb-regulated genes have been
identi¢ed, such as the chicken lysozyme gene [51], the tom-1
gene [52], the homeobox gene GBX2 [53], the c-kit gene [54]
and the Bcl-2 gene [55,56]. The Myb-binding sites de¢ned
within these promoter regions all contain an AAC core ele-
ment which is required for the Myb proteins to bind e⁄ciently
to the MRE [17]. Nevertheless, none of the Myb-binding sites
other than the mim1A site in the mim-1 promoter contains a
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downstream extension of the MRE by a stretch of six Ts. Our
binding site selection data, gel shift data and QT6 trans-acti-
vation data clearly show that the mim1A site is the most ideal
MRE known. Since none of the MREs described so far con-
tains an additional motif #2 (T-stretch) downstream of the
MRE, we believe that nature has other ways to assemble
strong promoter elements. For example, other regulatory fac-
tors may bind to adjacent speci¢c DNA elements or bind to
Myb itself and function as co-activators that regulate the ex-
pression of target genes in conjunction with the Myb tran-
scription factors. Such a regulatory factor would distort the
local promoter structure to a similar extent like the T-stretch
in the mim1A site so that a functional Myb-MRE complex
can be formed. This would also provide an additional level of
regulation on Myb-responsive genes. Interestingly, several of
the Myb target genes described so far require another mye-
loid-speci¢c transcription factor, NF-M, a homologue of the
mammalian C/EBP protein [57], for full induction. This was
shown for the mim-1 and the tom-1 gene [52,58]. Our favored
model is outlined in Fig. 3A, which suggests that formation of
a functional Myb-MRE complex requires a certain tertiary
local promoter structure for direct or indirect interaction
with the basic transcription machinery. This complex can ei-
ther be obtained through the rigid structure of a downstream
T-stretch or through a regulatory factor Y that induces a
similar kind of bend. In the case of the mim-1 promoter,
two potential NF-M-binding sites are found besides the three
MREs. One is located at position 360, just upstream of the
mim1A site at the proper site relative to the MRE, and the
second downstream, closer to the start site [58]. Both NF-M
sites are required for full induction of the mim-1 gene [58],
but whether NF-M has factor ‘Y’ function within the context
of the mim-1 promoter is not clear yet and has to be inves-
tigated.
Besides c-Myb and NF-M (b-ZIP) that cooperate to regu-
late the chicken mim-1 gene [58], there are additional examples
of other Myb-related proteins that must bind directly adjacent
to transcription factors with other classes of DBDs for speci¢c
target gene expression. In each case, a Myb family protein and
a DNA-binding protein of another family have been shown to
co-regulate a speci¢c target gene by occupation of adjacent
binding sites within the same promoter region. For example,
c-Myb and AML1 (Runt) regulate expression of the murine
T-cell receptor delta enhancer [59], C1 (Myb) and R (helix-
loop-helix) regulate expression of the maize Bronze1 gene [60],
Bas1 (Myb) and Bas2/Pho2 (Homeo) regulate expression of
the yeast HIS4 gene [61]. These four given examples are sum-
marized in Fig. 3B. Whether any of these other classes of
DNA-binding proteins have DNA-bending ability is not clear,
although recent evidence suggests that the Runt domain pro-
teins can bend DNA [62]. A major challenge for future re-
search is to elucidate the required conformations of Myb-
MRE-Y complexes in greater detail. Such insights may pro-
vide a crucial key to the elusive goal of Myb-speci¢c target
gene expression.
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